| (R)-noradrenaline | multiple interactions | ISO | RGD:733809 | 6480464 | SLC6A3 protein promotes the reaction [Norepinephrine results in increased activity of TAAR1 protein] | CTD | PMID:17234900 |
| (R)-noradrenaline | increases uptake | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased uptake of Norepinephrine | CTD | PMID:17250655 |
| (S)-amphetamine | increases activity | ISO | RGD:11315 | 6480464 | Dextroamphetamine results in increased activity of SLC6A3 protein | CTD | PMID:12716422 |
| (S)-amphetamine | decreases expression | EXP | | 6480464 | Dextroamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:15900317 |
| (S)-amphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | GBR 12935 inhibits the reaction [Dextroamphetamine results in increased activity of SLC6A3 protein] | CTD | PMID:12716422 |
| (S)-amphetamine | affects response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the susceptibility to Dextroamphetamine | CTD | PMID:11797063 |
| (S)-nicotine | multiple interactions | ISO | RGD:11315 | 6480464 | Nicotine inhibits the reaction [Paraquat results in decreased expression of SLC6A3 protein] | CTD | PMID:17227438 |
| 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine | affects binding | ISO | RGD:11315 | 6480464 | GBR 12935 binds to SLC6A3 protein | CTD | PMID:11226678 |
| 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine | multiple interactions | EXP | | 6480464 | Paraquat inhibits the reaction [GBR 12935 binds to SLC6A3 protein] | CTD | PMID:16190885 more ... |
| 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine | affects binding | EXP | | 6480464 | GBR 12935 binds to SLC6A3 protein | CTD | PMID:15985715 more ... |
| 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine | multiple interactions | EXP | | 6480464 | Paraquat inhibits the reaction [GBR 12935 binds to SLC6A3 protein] | CTD | PMID:15985715 more ... |
| 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine | affects binding | EXP | | 6480464 | GBR 12935 binds to SLC6A3 protein | CTD | PMID:16190885 more ... |
| 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine | multiple interactions | EXP | | 6480464 | Paraquat inhibits the reaction [GBR 12935 binds to SLC6A3 protein] | CTD | PMID:17493592 more ... |
| 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine | affects binding | EXP | | 6480464 | GBR 12935 binds to SLC6A3 protein | CTD | PMID:17493592 more ... |
| 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine | multiple interactions | ISO | RGD:11315 | 6480464 | GBR 12935 inhibits the reaction [Dextroamphetamine results in increased activity of SLC6A3 protein] | CTD | PMID:12716422 |
| 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine | multiple interactions | ISO | RGD:11315 | 6480464 | NR3C1 protein inhibits the reaction [GBR 12935 binds to SLC6A3 protein] | CTD | PMID:11226678 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:11315 | 6480464 | [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in decreased expression of SLC6A3 protein | CTD | PMID:19653878 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | RGD:11315 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC6A3 protein | CTD | PMID:16725203 PMID:20079141 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | RGD:11315 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC6A3 mRNA | CTD | PMID:20079141 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:11315 | 6480464 | SLC6A3 protein promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased abundance of Dopamine]; more ... | CTD | PMID:22342763 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:11315 | 6480464 | Estradiol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of SLC6A3 protein]; more ... | CTD | PMID:16011487 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases activity | ISO | RGD:11315 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of SLC6A3 protein | CTD | PMID:16011487 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:11315 | 6480464 | Glyburide promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC6A3 protein] | CTD | PMID:16725203 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | RGD:11315 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC6A3 protein | CTD | PMID:16725203 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] inhibits the reaction [SLC6A3 protein affects the export of Dopamine]; more ... | CTD | PMID:19479021 |
| 17beta-estradiol | multiple interactions | ISO | RGD:733809 | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of SLC6A3 mRNA | CTD | PMID:20404318 |
| 17beta-estradiol | multiple interactions | ISO | RGD:11315 | 6480464 | Estradiol inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of SLC6A3 protein] | CTD | PMID:16011487 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SLC6A3 protein | CTD | PMID:16451217 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | ESR2 protein affects the reaction [Estradiol results in increased expression of SLC6A3 protein] | CTD | PMID:16451217 |
| 2-phenylethylamine | multiple interactions | ISO | RGD:733809 | 6480464 | Cocaine inhibits the reaction [SLC6A3 protein results in increased transport of phenethylamine] | CTD | PMID:15764732 |
| 2-phenylethylamine | increases transport | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased transport of phenethylamine | CTD | PMID:15764732 |
| 2-phenylethylamine | multiple interactions | ISO | RGD:733809 | 6480464 | SLC6A3 protein promotes the reaction [phenethylamine results in increased activity of TAAR1 protein] | CTD | PMID:17234900 |
| 4-nitrotoluene | decreases expression | EXP | | 6480464 | 4-nitrotoluene results in decreased expression of SLC6A3 mRNA | CTD | PMID:15265578 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SLC6A3 mRNA | CTD | PMID:16483693 |
| amphetamine | multiple interactions | ISO | RGD:733809 | 6480464 | SOD1 protein inhibits the reaction [Amphetamine results in decreased expression of SLC6A3 protein] | CTD | PMID:11731100 |
| amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of SLC6A3 mRNA | CTD | PMID:16126238 |
| amphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the reaction [Amphetamine results in increased expression of FOS protein] | CTD | PMID:12699766 |
| amphetamine | increases response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased susceptibility to Amphetamine | CTD | PMID:15602501 |
| amphetamine | decreases response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 3' UTR polymorphism results in decreased susceptibility to Amphetamine | CTD | PMID:15602501 |
| amphetamine | affects response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 3' UTR polymorphism affects the susceptibility to Amphetamine | CTD | PMID:19462300 |
| amphetamine | multiple interactions | ISO | RGD:733809 | 6480464 | Amphetamine inhibits the reaction [SLC6A3 protein mutant form results in increased export of Dopamine] | CTD | PMID:18614672 |
| amphetamine | multiple interactions | ISO | RGD:733809 | 6480464 | [Amphetamine co-treated with Zinc] results in decreased localization of SLC6A3 protein | CTD | PMID:16684900 |
| amphetamine | multiple interactions | ISO | RGD:733809 | 6480464 | [Amphetamine co-treated with SLC6A3 protein] results in increased expression of FOS mRNA; more ... | CTD | PMID:12112414 |
| amphetamine | affects localization | ISO | RGD:733809 | 6480464 | Amphetamine affects the localization of SLC6A3 protein | CTD | PMID:16684900 |
| amphetamine | decreases expression | ISO | RGD:11315 | 6480464 | Amphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:11731100 |
| Aroclor 1254 | multiple interactions | ISO | RGD:11315 | 6480464 | [Chlorodiphenyl (54% Chlorine) co-treated with aroclor 1260] inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine]; more ... | CTD | PMID:16702228 |
| Aroclor 1254 | decreases expression | ISO | RGD:11315 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC6A3 protein | CTD | PMID:22094459 |
| Aroclor 1254 | multiple interactions | EXP | | 6480464 | [aroclor 1242 co-treated with aroclor 1248 co-treated with Chlorodiphenyl (54% Chlorine) co-treated with aroclor 1260] results in decreased expression of SLC6A3 protein | CTD | PMID:17324953 |
| atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of SLC6A3 mRNA | CTD | PMID:23123945 |
| benzatropine | multiple interactions | ISO | RGD:733809 | 6480464 | Benztropine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] | CTD | PMID:17250655 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:11315 | 6480464 | Mustard Gas results in increased expression of SLC6A3 mRNA | CTD | PMID:15674844 |
| bisphenol A | affects localization | EXP | | 6480464 | bisphenol A affects the localization of SLC6A3 protein | CTD | PMID:19479021 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC6A3 mRNA | CTD | PMID:17689037 PMID:15079872 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC6A3 mRNA | CTD | PMID:15079872 PMID:17689037 |
| bisphenol A | multiple interactions | EXP | | 6480464 | bisphenol A affects the reaction [SLC6A3 protein affects the export of Dopamine]; more ... | CTD | PMID:19479021 |
| bupropion | multiple interactions | ISO | RGD:733809 | 6480464 | Bupropion inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS mRNA]; more ... | CTD | PMID:12112414 |
| cadmium dichloride | increases expression | ISO | RGD:733809 | 6480464 | Cadmium Chloride results in increased expression of SLC6A3 mRNA | CTD | PMID:12160620 |
| caffeine | increases response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 gene mutant form results in increased susceptibility to Caffeine | CTD | PMID:11222668 |
| calcitriol | increases expression | ISO | RGD:733809 | 6480464 | Calcitriol results in increased expression of SLC6A3 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:733809 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SLC6A3 mRNA | CTD | PMID:21592394 |
| chlorpyrifos | affects expression | EXP | | 6480464 | Chlorpyrifos affects the expression of SLC6A3 mRNA | CTD | PMID:18812211 |
| citalopram | multiple interactions | ISO | RGD:11315 | 6480464 | SLC6A3 mutant form promotes the reaction [Citalopram results in increased abundance of Dopamine] | CTD | PMID:14691264 |
| clozapine | affects response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 5' UTR affects the susceptibility to Clozapine | CTD | PMID:20580759 |
| cocaine | multiple interactions | ISO | RGD:733809 | 6480464 | Butyrates inhibits the reaction [Cocaine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine]] | CTD | PMID:17250655 |
| cocaine | multiple interactions | ISO | RGD:733809 | 6480464 | Cocaine inhibits the reaction [Melitten results in increased localization of SLC6A3 protein] | CTD | PMID:20969853 PMID:22683840 |
| cocaine | decreases response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 gene mutant form results in decreased susceptibility to Cocaine | CTD | PMID:22034972 |
| cocaine | multiple interactions | ISO | RGD:733809 | 6480464 | Cocaine promotes the reaction [(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester binds to SLC6A3 protein] | CTD | PMID:16110277 PMID:12064476 |
| cocaine | decreases expression | ISO | RGD:733809 | 6480464 | Cocaine results in decreased expression of SLC6A3 mRNA | CTD | PMID:10581411 more ... |
| cocaine | affects response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the susceptibility to Cocaine | CTD | PMID:12193195 PMID:11312315 |
| cocaine | increases expression | ISO | RGD:733809 | 6480464 | Cocaine results in increased expression of SLC6A3 protein | CTD | PMID:18565692 PMID:16110277 |
| cocaine | decreases expression | ISO | RGD:733809 | 6480464 | Cocaine results in decreased expression of SLC6A3 mRNA | CTD | PMID:9736005 more ... |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of SLC6A3 protein | CTD | PMID:11249581 |
| cocaine | multiple interactions | EXP | | 6480464 | vanoxerine affects the reaction [Cocaine affects the expression of SLC6A3 protein] | CTD | PMID:11249581 |
| cocaine | decreases expression | EXP | | 6480464 | Cocaine results in decreased expression of SLC6A3 protein | CTD | PMID:16179556 |
| cocaine | multiple interactions | EXP | | 6480464 | Cocaine promotes the reaction [SLC6A3 protein affects the uptake of Dopamine]; more ... | CTD | PMID:20035724 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of SLC6A3 mRNA | CTD | PMID:11072100 |
| cocaine | affects response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the susceptibility to Cocaine | CTD | PMID:11312315 PMID:12193195 |
| cocaine | affects response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 mutant form affects the susceptibility to Cocaine | CTD | PMID:11320258 |
| cocaine | multiple interactions | ISO | RGD:11315 | 6480464 | SLC6A3 mutant form affects the reaction [Cocaine affects the abundance of and affects the uptake of Dopamine] | CTD | PMID:14691264 |
| cocaine | increases activity | ISO | RGD:11315 | 6480464 | Cocaine results in increased activity of SLC6A3 protein | CTD | PMID:11165777 |
| cocaine | multiple interactions | ISO | RGD:11315 | 6480464 | [Alcohols co-treated with Cocaine] results in increased activity of SLC6A3 protein; more ... | CTD | PMID:11165777 |
| cocaine | increases response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 gene polymorphism results in increased susceptibility to Cocaine | CTD | PMID:8825631 |
| cocaine | multiple interactions | ISO | RGD:733809 | 6480464 | Cocaine promotes the reaction [(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester binds to SLC6A3 protein] | CTD | PMID:12064476 PMID:16110277 |
| cocaine | increases expression | ISO | RGD:733809 | 6480464 | Cocaine results in increased expression of SLC6A3 protein | CTD | PMID:16110277 PMID:18565692 |
| cocaine | decreases expression | ISO | RGD:733809 | 6480464 | Cocaine results in decreased expression of SLC6A3 mRNA | CTD | PMID:10581411 more ... |
| cocaine | multiple interactions | ISO | RGD:733809 | 6480464 | Cocaine inhibits the reaction [SLC6A3 protein results in increased transport of phenethylamine] | CTD | PMID:15764732 |
| cocaine | affects binding | ISO | RGD:733809 | 6480464 | Cocaine binds to SLC6A3 protein | CTD | PMID:9372557 |
| cocaine | multiple interactions | ISO | RGD:733809 | 6480464 | [Cocaine co-treated with SLC6A3 protein] results in increased expression of FOS protein; more ... | CTD | PMID:12112414 |
| DDE | multiple interactions | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene inhibits the reaction [SLC6A3 protein affects the export of Dopamine]; more ... | CTD | PMID:19479021 |
| diazinon | affects expression | EXP | | 6480464 | Diazinon affects the expression of SLC6A3 mRNA | CTD | PMID:18812211 |
| dieldrin | decreases expression | ISO | RGD:11315 | 6480464 | Dieldrin results in decreased expression of SLC6A3 protein | CTD | PMID:17291500 |
| dieldrin | multiple interactions | EXP | | 6480464 | Dieldrin inhibits the reaction [SLC6A3 protein affects the export of Dopamine] | CTD | PMID:19479021 |
| dieldrin | increases expression | EXP | | 6480464 | Dieldrin results in increased expression of SLC6A3 protein | CTD | PMID:11719704 |
| dieldrin | increases expression | EXP | | 6480464 | Dieldrin results in increased expression of SLC6A3 mRNA | CTD | PMID:18812211 |
| dieldrin | increases expression | ISO | RGD:11315 | 6480464 | Dieldrin results in increased expression of SLC6A3 mRNA; more ... | CTD | PMID:16809432 |
| diethylstilbestrol | multiple interactions | EXP | | 6480464 | Diethylstilbestrol affects the reaction [SLC6A3 protein affects the export of Dopamine] | CTD | PMID:19479021 |
| dopamine | multiple interactions | ISO | RGD:733809 | 6480464 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS protein]; more ... | CTD | PMID:12112414 |
| dopamine | increases uptake | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased uptake of Dopamine | CTD | PMID:16005927 more ... |
| dopamine | multiple interactions | ISO | RGD:733809 | 6480464 | Melitten inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] | CTD | PMID:20969853 |
| dopamine | affects localization | ISO | RGD:733809 | 6480464 | Dopamine affects the localization of SLC6A3 protein | CTD | PMID:20875051 |
| dopamine | multiple interactions | ISO | RGD:733809 | 6480464 | Nomifensine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine]; more ... | CTD | PMID:20875051 |
| dopamine | increases uptake | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased uptake of Dopamine | CTD | PMID:16005927 more ... |
| dopamine | multiple interactions | ISO | RGD:11315 | 6480464 | SLC6A3 protein promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased abundance of Dopamine]; more ... | CTD | PMID:22342763 |
| dopamine | affects export | EXP | | 6480464 | SLC6A3 protein affects the export of Dopamine | CTD | PMID:19479021 |
| dopamine | multiple interactions | EXP | | 6480464 | bisphenol A affects the reaction [SLC6A3 protein affects the export of Dopamine]; more ... | CTD | PMID:19479021 |
| dopamine | increases uptake | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased uptake of Dopamine | CTD | PMID:16005927 PMID:17250655 |
| dopamine | multiple interactions | EXP | | 6480464 | Cocaine promotes the reaction [SLC6A3 protein affects the uptake of Dopamine] | CTD | PMID:20035724 |
| dopamine | multiple interactions | EXP | | 6480464 | modafinil inhibits the reaction [SLC6A3 protein affects the uptake of Dopamine] | CTD | PMID:19197004 |
| dopamine | multiple interactions | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the reaction [Methamphetamine affects the abundance of Dopamine] | CTD | PMID:9634552 |
| dopamine | multiple interactions | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the reaction [Alcohols results in increased uptake of Dopamine]; more ... | CTD | PMID:11165777 |
| dopamine | affects abundance | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the abundance of Dopamine | CTD | PMID:18690110 |
| dopamine | multiple interactions | ISO | RGD:11315 | 6480464 | SLC6A3 mutant form affects the reaction [Cocaine affects the abundance of and affects the uptake of Dopamine]; more ... | CTD | PMID:14691264 |
| dopamine | multiple interactions | ISO | RGD:11315 | 6480464 | Heptachlor promotes the reaction [SLC6A3 protein results in increased uptake of Dopamine] | CTD | PMID:11294980 |
| dopamine | multiple interactions | ISO | RGD:11315 | 6480464 | [Chlorodiphenyl (54% Chlorine) co-treated with aroclor 1260] inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] | CTD | PMID:16702228 |
| dopamine | increases transport | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased transport of Dopamine | CTD | PMID:11707631 |
| dopamine | increases uptake | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased uptake of Dopamine | CTD | PMID:17250655 PMID:16005927 |
| dopamine | increases export | ISO | RGD:733809 | 6480464 | SLC6A3 protein mutant form results in increased export of Dopamine | CTD | PMID:18614672 |
| dopamine | multiple interactions | ISO | RGD:733809 | 6480464 | indatraline inhibits the reaction [SLC6A3 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein]]; more ... | CTD | PMID:17234900 |
| dopamine | multiple interactions | ISO | RGD:733809 | 6480464 | decamethrin inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine]; more ... | CTD | PMID:16005927 |
| dopamine | multiple interactions | ISO | RGD:733809 | 6480464 | Benztropine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine]; more ... | CTD | PMID:17250655 |
| dopamine | multiple interactions | ISO | RGD:733809 | 6480464 | Amphetamine inhibits the reaction [SLC6A3 protein mutant form results in increased export of Dopamine]; more ... | CTD | PMID:18614672 |
| endosulfan | multiple interactions | EXP | | 6480464 | Endosulfan inhibits the reaction [SLC6A3 protein affects the export of Dopamine] | CTD | PMID:19479021 |
| estrone | multiple interactions | ISO | RGD:11315 | 6480464 | Estrone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of SLC6A3 protein] | CTD | PMID:16011487 |
| fluoxetine | multiple interactions | ISO | RGD:11315 | 6480464 | SLC6A3 mutant form affects the reaction [Fluoxetine affects the abundance of Dopamine] | CTD | PMID:14691264 |
| fluoxetine | affects response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the susceptibility to Fluoxetine | CTD | PMID:11797063 |
| glyburide | multiple interactions | ISO | RGD:11315 | 6480464 | Glyburide promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC6A3 protein] | CTD | PMID:16725203 |
| GM1 ganglioside | increases expression | EXP | | 6480464 | G(M1) Ganglioside results in increased expression of SLC6A3 mRNA | CTD | PMID:14552908 |
| haloperidol | multiple interactions | ISO | RGD:11315 | 6480464 | SLC6A3 protein promotes the reaction [Haloperidol results in increased expression of NTS mRNA] | CTD | PMID:14698760 |
| haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of SLC6A3 protein | CTD | PMID:17069804 |
| heptachlor | multiple interactions | ISO | RGD:11315 | 6480464 | Heptachlor promotes the reaction [SLC6A3 protein results in increased uptake of Dopamine] | CTD | PMID:11294980 |
| heptachlor | increases expression | ISO | RGD:11315 | 6480464 | Heptachlor results in increased expression of SLC6A3 protein | CTD | PMID:10499361 more ... |
| heptachlor | increases expression | ISO | RGD:11315 | 6480464 | Heptachlor results in increased expression of SLC6A3 mRNA | CTD | PMID:18577399 |
| heptachlor | increases expression | ISO | RGD:11315 | 6480464 | Heptachlor results in increased expression of SLC6A3 protein | CTD | PMID:10499361 more ... |
| heptachlor | increases expression | ISO | RGD:11315 | 6480464 | Heptachlor results in increased expression of SLC6A3 protein | CTD | PMID:11294980 more ... |
| heptachlor | increases expression | ISO | RGD:11315 | 6480464 | Heptachlor results in increased expression of SLC6A3 protein | CTD | PMID:12428726 more ... |
| heptachlor | increases expression | ISO | RGD:11315 | 6480464 | Heptachlor results in increased expression of SLC6A3 protein | CTD | PMID:11294980 more ... |
| heptachlor | increases expression | ISO | RGD:11315 | 6480464 | Heptachlor results in increased expression of SLC6A3 protein | CTD | PMID:11294980 more ... |
| heptachlor | increases expression | EXP | | 6480464 | Heptachlor results in increased expression of SLC6A3 protein | CTD | PMID:11719704 |
| ibuprofen | multiple interactions | ISO | RGD:11315 | 6480464 | Ibuprofen inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] | CTD | PMID:18946735 |
| isoliquiritigenin | multiple interactions | ISO | RGD:11315 | 6480464 | isoliquiritigenin inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] | CTD | PMID:19834288 |
| linalool | decreases expression | EXP | | 6480464 | linalool results in decreased expression of SLC6A3 mRNA | CTD | PMID:20536181 |
| maneb | multiple interactions | ISO | RGD:11315 | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of SLC6A3 protein | CTD | PMID:11124998 |
| maneb | multiple interactions | ISO | RGD:11315 | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of SLC6A3 mRNA | CTD | PMID:18386188 |
| maneb | affects response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 gene polymorphism affects the susceptibility to Maneb | CTD | PMID:19590691 |
| manganese atom | decreases expression | EXP | | 6480464 | Manganese results in decreased expression of SLC6A3 protein | CTD | PMID:16571372 |
| manganese atom | increases response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased susceptibility to Manganese | CTD | PMID:18206288 |
| manganese(0) | decreases expression | EXP | | 6480464 | Manganese results in decreased expression of SLC6A3 protein | CTD | PMID:16571372 |
| manganese(0) | increases response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased susceptibility to Manganese | CTD | PMID:18206288 |
| manganese(II) chloride | decreases expression | EXP | | 6480464 | manganese chloride results in decreased expression of SLC6A3 protein | CTD | PMID:16571372 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Rotenone results in decreased expression of SLC6A3 protein] | CTD | PMID:18289173 |
| mepyramine | multiple interactions | ISO | RGD:733809 | 6480464 | Pyrilamine analog binds to and affects the activity of SLC6A3 protein | CTD | PMID:11931612 |
| methamphetamine | increases response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 3' UTR polymorphism results in increased susceptibility to Methamphetamine | CTD | PMID:12931138 |
| methamphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | NR4A2 protein affects the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] | CTD | PMID:21151937 |
| methamphetamine | decreases expression | ISO | RGD:11315 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:10559418 more ... |
| methamphetamine | decreases expression | ISO | RGD:733809 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:12944350 more ... |
| methamphetamine | decreases activity | EXP | | 6480464 | Methamphetamine results in decreased activity of SLC6A3 protein | CTD | PMID:11032899 more ... |
| methamphetamine | decreases expression | ISO | RGD:11315 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:10559418 more ... |
| methamphetamine | decreases activity | EXP | | 6480464 | Methamphetamine results in decreased activity of SLC6A3 protein | CTD | PMID:11032899 more ... |
| methamphetamine | decreases expression | ISO | RGD:11315 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:12871582 more ... |
| methamphetamine | decreases expression | ISO | RGD:733809 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:17992686 more ... |
| methamphetamine | decreases activity | EXP | | 6480464 | Methamphetamine results in decreased activity of SLC6A3 protein | CTD | PMID:19046384 more ... |
| methamphetamine | decreases expression | ISO | RGD:11315 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:10559418 more ... |
| methamphetamine | decreases expression | ISO | RGD:733809 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:9763484 more ... |
| methamphetamine | affects response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the susceptibility to Methamphetamine | CTD | PMID:12050851 PMID:20558209 |
| methamphetamine | decreases expression | ISO | RGD:11315 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:9765353 more ... |
| methamphetamine | decreases expression | ISO | RGD:733809 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:16518646 more ... |
| methamphetamine | decreases activity | EXP | | 6480464 | Methamphetamine results in decreased activity of SLC6A3 protein | CTD | PMID:19046384 more ... |
| methamphetamine | decreases expression | ISO | RGD:11315 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:12871582 more ... |
| methamphetamine | decreases expression | ISO | RGD:733809 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:12944350 more ... |
| methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:19648469 PMID:15900317 |
| methamphetamine | decreases expression | ISO | RGD:11315 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:18946735 more ... |
| methamphetamine | decreases expression | ISO | RGD:733809 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:12944350 more ... |
| methamphetamine | affects abundance | ISO | RGD:733809 | 6480464 | SLC6A3 protein affects the abundance of Methamphetamine | CTD | PMID:11027249 |
| methamphetamine | decreases activity | ISO | RGD:733809 | 6480464 | Methamphetamine results in decreased activity of SLC6A3 protein | CTD | PMID:16842981 |
| methamphetamine | decreases expression | ISO | RGD:733809 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:16518646 more ... |
| methamphetamine | multiple interactions | ISO | RGD:733809 | 6480464 | indatraline inhibits the reaction [SLC6A3 protein promotes the reaction [Methamphetamine results in increased activity of TAAR1 protein]]; more ... | CTD | PMID:17234900 |
| methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:15900317 PMID:19648469 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of SLC6A3 protein | CTD | PMID:15986185 |
| methamphetamine | decreases activity | EXP | | 6480464 | Methamphetamine results in decreased activity of SLC6A3 protein | CTD | PMID:19326567 more ... |
| methamphetamine | multiple interactions | EXP | | 6480464 | Methamphetamine inhibits the reaction [(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester binds to SLC6A3 protein] | CTD | PMID:16897726 |
| methamphetamine | multiple interactions | EXP | | 6480464 | Methamphetamine inhibits the reaction [Mazindol binds to SLC6A3 protein] | CTD | PMID:9132989 |
| methamphetamine | affects response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the susceptibility to Methamphetamine | CTD | PMID:20558209 PMID:12050851 |
| methamphetamine | decreases response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 gene mutant form results in decreased susceptibility to Methamphetamine | CTD | PMID:11222668 |
| methamphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the reaction [Methamphetamine affects the abundance of Dopamine]; more ... | CTD | PMID:9634552 |
| methamphetamine | decreases expression | ISO | RGD:11315 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 protein | CTD | PMID:20575850 more ... |
| methamphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | Minocycline inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] | CTD | PMID:16839653 |
| methamphetamine | decreases expression | ISO | RGD:11315 | 6480464 | Methamphetamine results in decreased expression of SLC6A3 mRNA | CTD | PMID:15249736 |
| methamphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | Methamphetamine inhibits the reaction [Mazindol binds to SLC6A3 protein]; more ... | CTD | PMID:11085313 |
| methamphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | isoliquiritigenin inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] | CTD | PMID:19834288 |
| methamphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | IL6 protein affects the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] | CTD | PMID:11093760 |
| methamphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | IFNG protein inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] | CTD | PMID:18282668 |
| methamphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | FOS protein affects the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] | CTD | PMID:10559418 |
| methamphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | Enkephalin, Leucine-2-Alanine inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein]; more ... | CTD | PMID:9765353 |
| methamphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | 7-nitroindazole inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein]; more ... | CTD | PMID:20575850 |
| methamphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | estradiol 3-benzoate inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 mRNA]; more ... | CTD | PMID:15249736 |
| methamphetamine | multiple interactions | ISO | RGD:11315 | 6480464 | 15-deoxyprostaglandin J2 inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein]; more ... | CTD | PMID:18946735 |
| methoxychlor | decreases expression | ISO | RGD:11315 | 6480464 | Methoxychlor results in decreased expression of SLC6A3 protein | CTD | PMID:19459224 |
| methylphenidate | multiple interactions | ISO | RGD:733809 | 6480464 | Methylphenidate inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS mRNA]; more ... | CTD | PMID:12112414 |
| methylphenidate | decreases expression | ISO | RGD:11315 | 6480464 | Methylphenidate results in decreased expression of SLC6A3 mRNA | CTD | PMID:22470460 |
| methylphenidate | decreases expression | ISO | RGD:733809 | 6480464 | Methylphenidate results in decreased expression of SLC6A3 protein | CTD | PMID:15059031 PMID:16139732 |
| methylphenidate | increases response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 protein results in increased susceptibility to Methylphenidate | CTD | PMID:12699766 |
| methylphenidate | multiple interactions | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the reaction [Methylphenidate results in increased expression of FOS protein] | CTD | PMID:12699766 |
| methylphenidate | affects response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 3' UTR polymorphism affects the susceptibility to Methylphenidate | CTD | PMID:19462300 |
| methylphenidate | decreases expression | ISO | RGD:733809 | 6480464 | Methylphenidate results in decreased expression of SLC6A3 protein | CTD | PMID:16139732 PMID:15059031 |
| methylphenidate | multiple interactions | ISO | RGD:733809 | 6480464 | Methylphenidate inhibits the reaction [SLC6A3 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein]]; more ... | CTD | PMID:17234900 |
| methylphenidate | multiple interactions | ISO | RGD:733809 | 6480464 | Methylphenidate inhibits the reaction [SLC6A3 protein mutant form results in increased export of Dopamine] | CTD | PMID:18614672 |
| minocycline | multiple interactions | ISO | RGD:11315 | 6480464 | Minocycline inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] | CTD | PMID:16839653 |
| N-ethyl-N-nitrosourea | increases mutagenesis | EXP | | 6480464 | Ethylnitrosourea results in increased mutagenesis of SLC6A3 gene | CTD | PMID:16495775 |
| N-methyl-4-phenylpyridinium | multiple interactions | ISO | RGD:733809 | 6480464 | 1-Methyl-4-phenylpyridinium inhibits the reaction [(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester binds to SLC6A3 protein] | CTD | PMID:17250655 |
| N-methyl-4-phenylpyridinium | increases response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased susceptibility to 1-Methyl-4-phenylpyridinium | CTD | PMID:12151787 more ... |
| N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of SLC6A3 protein | CTD | PMID:19794909 |
| N-methyl-4-phenylpyridinium | increases response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased susceptibility to 1-Methyl-4-phenylpyridinium | CTD | PMID:12151787 PMID:18206288 |
| N-methyl-4-phenylpyridinium | increases response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased susceptibility to 1-Methyl-4-phenylpyridinium | CTD | PMID:18206288 PMID:12151787 |
| N-methyl-4-phenylpyridinium | multiple interactions | ISO | RGD:733809 | 6480464 | [Mazindol results in decreased activity of SLC6A3 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium; more ... | CTD | PMID:18206288 |
| N-methyl-4-phenylpyridinium | increases response to substance | EXP | | 6480464 | SLC6A3 protein results in increased susceptibility to 1-Methyl-4-phenylpyridinium | CTD | PMID:10881039 |
| N-methyl-4-phenylpyridinium | increases uptake | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium | CTD | PMID:17250655 |
| N-methyl-4-phenylpyridinium | multiple interactions | ISO | RGD:733809 | 6480464 | SNCA protein affects the reaction [SLC6A3 protein results in increased susceptibility to 1-Methyl-4-phenylpyridinium]; more ... | CTD | PMID:12151787 |
| N-methyl-4-phenylpyridinium | affects response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 protein affects the susceptibility to 1-Methyl-4-phenylpyridinium | CTD | PMID:12151787 |
| N-methyl-4-phenylpyridinium | increases response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased susceptibility to 1-Methyl-4-phenylpyridinium | CTD | PMID:12151787 |
| naltrexone | multiple interactions | ISO | RGD:11315 | 6480464 | Naltrexone inhibits the reaction [Enkephalin, Leucine-2-Alanine inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein]] | CTD | PMID:9765353 |
| naltrexone | affects response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 gene polymorphism affects the susceptibility to Naltrexone | CTD | PMID:18552399 |
| nomifensine | multiple interactions | EXP | | 6480464 | Nomifensine inhibits the reaction [Rotenone results in decreased expression of SLC6A3 protein] | CTD | PMID:18289173 |
| nomifensine | multiple interactions | ISO | RGD:733809 | 6480464 | Nomifensine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] | CTD | PMID:20875051 |
| nomifensine | multiple interactions | ISO | RGD:733809 | 6480464 | [Nomifensine results in decreased activity of SLC6A3 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium | CTD | PMID:18206288 |
| octopamine | multiple interactions | ISO | RGD:733809 | 6480464 | SLC6A3 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein]; more ... | CTD | PMID:17234900 |
| oleic acid | multiple interactions | ISO | RGD:11315 | 6480464 | PPARA protein promotes the reaction [Oleic Acid results in increased expression of SLC6A3 mRNA] | CTD | PMID:18489776 |
| paraquat | multiple interactions | ISO | RGD:11315 | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of SLC6A3 protein | CTD | PMID:11124998 |
| paraquat | multiple interactions | ISO | RGD:11315 | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of SLC6A3 mRNA | CTD | PMID:18386188 |
| paraquat | decreases expression | ISO | RGD:11315 | 6480464 | Paraquat results in decreased expression of SLC6A3 protein | CTD | PMID:17227438 PMID:20079141 |
| paraquat | decreases expression | ISO | RGD:11315 | 6480464 | Paraquat results in decreased expression of SLC6A3 mRNA | CTD | PMID:20079141 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of SLC6A3 protein; more ... | CTD | PMID:20553223 |
| paraquat | multiple interactions | EXP | | 6480464 | Paraquat promotes the reaction [Zinc Sulfate results in increased expression of SLC6A3 protein]; more ... | CTD | PMID:20553223 |
| paraquat | multiple interactions | EXP | | 6480464 | Paraquat inhibits the reaction [GBR 12935 binds to SLC6A3 protein] | CTD | PMID:15985715 more ... |
| paraquat | multiple interactions | EXP | | 6480464 | Paraquat inhibits the reaction [GBR 12935 binds to SLC6A3 protein] | CTD | PMID:16190885 more ... |
| paraquat | multiple interactions | EXP | | 6480464 | Paraquat inhibits the reaction [GBR 12935 binds to SLC6A3 protein] | CTD | PMID:16190885 more ... |
| paraquat | affects response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 gene polymorphism affects the susceptibility to Paraquat | CTD | PMID:19590691 |
| paraquat | multiple interactions | EXP | | 6480464 | Paraquat inhibits the reaction [GBR 12935 binds to SLC6A3 protein] | CTD | PMID:17493592 more ... |
| paraquat | multiple interactions | EXP | | 6480464 | Paraquat inhibits the reaction [GBR 12935 binds to SLC6A3 protein] | CTD | PMID:15985715 more ... |
| paraquat | decreases expression | ISO | RGD:11315 | 6480464 | Paraquat results in decreased expression of SLC6A3 protein | CTD | PMID:17227438 |
| paraquat | multiple interactions | ISO | RGD:11315 | 6480464 | Nicotine inhibits the reaction [Paraquat results in decreased expression of SLC6A3 protein] | CTD | PMID:17227438 |
| permethrin | affects activity | ISO | RGD:733809 | 6480464 | Permethrin affects the activity of SLC6A3 protein | CTD | PMID:16005927 |
| permethrin | increases expression | ISO | RGD:11315 | 6480464 | Permethrin results in increased expression of SLC6A3 protein | CTD | PMID:12428726 more ... |
| permethrin | increases expression | ISO | RGD:11315 | 6480464 | Permethrin results in increased expression of SLC6A3 protein | CTD | PMID:14575646 more ... |
| permethrin | increases expression | ISO | RGD:11315 | 6480464 | Permethrin results in increased expression of SLC6A3 protein | CTD | PMID:16005927 more ... |
| permethrin | increases expression | ISO | RGD:11315 | 6480464 | Permethrin results in increased expression of SLC6A3 protein | CTD | PMID:12428726 more ... |
| permethrin | decreases expression | ISO | RGD:11315 | 6480464 | Permethrin results in decreased expression of SLC6A3 protein | CTD | PMID:14555407 |
| permethrin | multiple interactions | ISO | RGD:733809 | 6480464 | Permethrin inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] | CTD | PMID:16005927 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:733809 | 6480464 | Tetradecanoylphorbol Acetate results in increased localization of [SLC6A3 protein co-treated with EEA1 protein] | CTD | PMID:22683840 |
| pirinixic acid | multiple interactions | ISO | RGD:733809 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC6A3 mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | ISO | RGD:11315 | 6480464 | pirinixic acid results in increased expression of SLC6A3 mRNA | CTD | PMID:17426115 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of SLC6A3 mRNA | CTD | PMID:19162173 |
| probenecid | multiple interactions | ISO | RGD:11315 | 6480464 | [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in decreased expression of SLC6A3 protein | CTD | PMID:19653878 |
| quinolinic acid | decreases expression | EXP | | 6480464 | Quinolinic Acid results in decreased expression of SLC6A3 protein | CTD | PMID:12207953 |
| quinolinic acid | increases expression | EXP | | 6480464 | Quinolinic Acid results in increased expression of SLC6A3 protein | CTD | PMID:12207953 |
| raloxifene | increases expression | EXP | | 6480464 | Raloxifene results in increased expression of SLC6A3 protein | CTD | PMID:16451217 |
| reserpine | decreases activity | ISO | RGD:11315 | 6480464 | Reserpine results in decreased activity of SLC6A3 protein | CTD | PMID:17664021 |
| reserpine | affects response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 gene mutant form affects the susceptibility to Reserpine | CTD | PMID:19615345 |
| rotenone | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Rotenone results in decreased expression of SLC6A3 protein]; more ... | CTD | PMID:18289173 |
| rotenone | increases response to substance | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased susceptibility to Rotenone | CTD | PMID:18206288 |
| rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of SLC6A3 protein | CTD | PMID:18579341 |
| rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of SLC6A3 protein | CTD | PMID:18289173 |
| serotonin | multiple interactions | ISO | RGD:733809 | 6480464 | SLC6A3 protein promotes the reaction [Serotonin results in increased activity of TAAR1 protein] | CTD | PMID:17234900 |
| serotonin | increases uptake | ISO | RGD:733809 | 6480464 | SLC6A3 protein results in increased uptake of Serotonin | CTD | PMID:17250655 |
| sulpiride | multiple interactions | ISO | RGD:733809 | 6480464 | Sulpiride inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine]; more ... | CTD | PMID:20875051 |
| tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of SLC6A3 protein | CTD | PMID:16451217 |
| testosterone | multiple interactions | ISO | RGD:733809 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SLC6A3 mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | ISO | RGD:733809 | 6480464 | Testosterone results in increased expression of SLC6A3 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of SLC6A3 mRNA | CTD | PMID:17805973 |
| toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of SLC6A3 mRNA | CTD | PMID:18653662 |
| tryptamine | multiple interactions | ISO | RGD:733809 | 6480464 | indatraline inhibits the reaction [SLC6A3 protein promotes the reaction [tryptamine results in increased activity of TAAR1 protein]]; more ... | CTD | PMID:17234900 |
| tyramine | multiple interactions | ISO | RGD:733809 | 6480464 | indatraline inhibits the reaction [SLC6A3 protein promotes the reaction [Tyramine results in increased activity of TAAR1 protein]]; more ... | CTD | PMID:17234900 |
| vanoxerine dihydrochloride | multiple interactions | ISO | RGD:733809 | 6480464 | vanoxerine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] | CTD | PMID:17250655 |
| vanoxerine dihydrochloride | decreases activity | ISO | RGD:11315 | 6480464 | vanoxerine results in decreased activity of SLC6A3 protein | CTD | PMID:19616025 PMID:22342763 |
| vanoxerine dihydrochloride | multiple interactions | ISO | RGD:11315 | 6480464 | vanoxerine inhibits the reaction [SLC6A3 protein promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased abundance of Dopamine]] | CTD | PMID:22342763 |
| vanoxerine dihydrochloride | multiple interactions | ISO | RGD:733809 | 6480464 | [vanoxerine results in decreased activity of SLC6A3 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium | CTD | PMID:18206288 |
| vanoxerine dihydrochloride | multiple interactions | EXP | | 6480464 | vanoxerine affects the reaction [Cocaine affects the expression of SLC6A3 protein] | CTD | PMID:11249581 |
| vanoxerine dihydrochloride | affects response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 protein affects the susceptibility to vanoxerine | CTD | PMID:11312315 |
| vanoxerine dihydrochloride | decreases response to substance | ISO | RGD:11315 | 6480464 | SLC6A3 gene mutant form results in decreased susceptibility to vanoxerine | CTD | PMID:11222668 |
| vanoxerine dihydrochloride | affects binding | ISO | RGD:733809 | 6480464 | vanoxerine binds to SLC6A3 protein | CTD | PMID:11249581 |
| wortmannin | multiple interactions | ISO | RGD:733809 | 6480464 | wortmannin inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] | CTD | PMID:20875051 |
| zinc atom | multiple interactions | ISO | RGD:733809 | 6480464 | [Amphetamine co-treated with Zinc] results in decreased localization of SLC6A3 protein | CTD | PMID:16684900 |
| zinc atom | decreases activity | ISO | RGD:733809 | 6480464 | Zinc results in decreased activity of SLC6A3 protein | CTD | PMID:16684900 |
| zinc sulfate | multiple interactions | EXP | | 6480464 | Paraquat promotes the reaction [Zinc Sulfate results in increased expression of SLC6A3 mRNA]; more ... | CTD | PMID:20553223 |
| zinc sulfate | increases expression | EXP | | 6480464 | Zinc Sulfate results in increased expression of SLC6A3 mRNA; more ... | CTD | PMID:20553223 |
| zinc(0) | multiple interactions | ISO | RGD:733809 | 6480464 | [Amphetamine co-treated with Zinc] results in decreased localization of SLC6A3 protein | CTD | PMID:16684900 |
| zinc(0) | decreases activity | ISO | RGD:733809 | 6480464 | Zinc results in decreased activity of SLC6A3 protein | CTD | PMID:16684900 |